4036 related articles for article (PubMed ID: 26642102)
21. Metabolic Syndrome: Polycystic Ovary Syndrome.
Mortada R; Williams T
FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
[TBL] [Abstract][Full Text] [Related]
22. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.
Harwood K; Vuguin P; DiMartino-Nardi J
Horm Res; 2007; 68(5):209-17. PubMed ID: 17426408
[TBL] [Abstract][Full Text] [Related]
23. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
24. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.
Zhu S; Zhang B; Jiang X; Li Z; Zhao S; Cui L; Chen ZJ
Fertil Steril; 2019 Jan; 111(1):168-177. PubMed ID: 30611404
[TBL] [Abstract][Full Text] [Related]
25. Ovulation induction in polycystic ovary syndrome.
Vause TDR; Cheung AP;
J Obstet Gynaecol Can; 2010 May; 32(5):495-502. PubMed ID: 20500959
[TBL] [Abstract][Full Text] [Related]
26. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy complications in women with polycystic ovary syndrome.
Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
[TBL] [Abstract][Full Text] [Related]
28. Benefit of Delayed Fertility Therapy With Preconception Weight Loss Over Immediate Therapy in Obese Women With PCOS.
Legro RS; Dodson WC; Kunselman AR; Stetter CM; Kris-Etherton PM; Williams NI; Gnatuk CL; Estes SJ; Allison KC; Sarwer DB; Diamond MP; Schlaff WD; Casson PR; Christman GM; Barnhart KT; Bates GW; Usadi R; Lucidi S; Baker V; Zhang H; Eisenberg E; Coutifaris C; Dokras A
J Clin Endocrinol Metab; 2016 Jul; 101(7):2658-66. PubMed ID: 27172435
[TBL] [Abstract][Full Text] [Related]
29. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
30. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Treatment of Polycystic Ovary Syndrome.
Williams T; Mortada R; Porter S
Am Fam Physician; 2016 Jul; 94(2):106-13. PubMed ID: 27419327
[TBL] [Abstract][Full Text] [Related]
32. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.
Ezeh U; Ezeh C; Pisarska MD; Azziz R
Fertil Steril; 2021 Jun; 115(6):1557-1568. PubMed ID: 33602559
[TBL] [Abstract][Full Text] [Related]
33. [Polycystic ovary syndrome - current state of knowledge].
Marciniak A; Lejman-Larysz K; Nawrocka-Rutkowska J; Brodowska A; Songin D
Pol Merkur Lekarski; 2018 Jun; 44(264):296-301. PubMed ID: 30057399
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
35. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
36. Metformin and intervention in polycystic ovary syndrome. Endocrine Society of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group.
Norman RJ; Kidson WJ; Cuneo RC; Zacharin MR
Med J Aust; 2001 Jun; 174(11):580-3. PubMed ID: 11453331
[TBL] [Abstract][Full Text] [Related]
37. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
[TBL] [Abstract][Full Text] [Related]
38. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S; Mateen S; Ahmad R; Moin S
J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
[TBL] [Abstract][Full Text] [Related]
39. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.
Sivalingam VN; Myers J; Nicholas S; Balen AH; Crosbie EJ
Hum Reprod Update; 2014; 20(6):853-68. PubMed ID: 25013215
[TBL] [Abstract][Full Text] [Related]
40. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
